Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS's average EBITDA Per Share Growth Rate was -40.90% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 46.30% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 118.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS (IST:TNZTP) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS 3-Year EBITDA Growth Rate Related Terms
IST:TNZTP vs HCA, THC, EHC: 3-Year EBITDA Growth Rate Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 46.30% mean?
Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS (IST:TNZTP) has a 3-Year EBITDA Growth Rate of 46.30% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS and its competitors. This is 71% below median its historical median of 159.95. Over the past decade, Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS's 3-Year EBITDA Growth Rate has ranged from 46.30 to 235.40. According to the industry distribution chart, Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS ranks #57 out of 526 companies in the Healthcare Providers & Services industry, placing it in the top 10.8%.
Is Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS's 3-Year EBITDA Growth Rate too high?
Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS's current 3-Year EBITDA Growth Rate of 46.30% is 71% below median its 10-year median of 159.95. Over the past 10 years, this metric has ranged from a low of 46.30 to a high of 235.40. The Healthcare Providers & Services industry median 3-Year EBITDA Growth Rate is 10.05. Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS's value of 46.30% is 360.7% above this industry median. Based on the distribution chart, Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS ranks #57 out of 526 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS's 3-Year EBITDA Growth Rate compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS ranks #57 out of 526 companies for 3-Year EBITDA Growth Rate. This places Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS in the top 11% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 10.05. Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS's value of 46.30% is 360.7% above this benchmark. Historically, Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS's own 3-Year EBITDA Growth Rate has ranged from 46.30 to 235.40 over the past decade. While the company's 10-year median is 159.95 vs. the industry median of 10.05, Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.05, based on 526 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS's current 3-Year EBITDA Growth Rate of 46.30% is 360.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS's current 3-Year EBITDA Growth Rate is 46.30%, which is 71% below median its own 10-year median of 159.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS stock overvalued right now?
Based on GuruFocus' analysis, Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS (IST:TNZTP) is currently considered Fairly Valued. The stock's GF Value™ is ₺30.50, compared to a current price of ₺28.82 — trading 5.5% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 46.30%, which is 71% below median its 10-year median of 159.95 and 360.7% above the Healthcare Providers & Services industry median of 10.05. Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS's overall GF Score™ is 85/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS (IST:TNZTP), the current 3-Year EBITDA Growth Rate is 46.30% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS (IST:TNZTP) Overvalued in 2026?
Based on GuruFocus' analysis, Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS stock appears to be undervalued.
The current stock price of ₺28.82 is trading 5.5% below its estimated GF Value™ of ₺30.50.
GuruFocus considers Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS to be Fairly Valued.
Key valuation signals for IST:TNZTP:
3-Year EBITDA Growth Rate: 46.30% (71% below median its 10-year median of 159.95)
GF Value™: ₺30.50 vs. price of ₺28.82 (5.5% below fair value)
Industry Position: 360.7% above the Healthcare Providers & Services median (#57 of 526)
No single metric tells the full story. See the IST:TNZTP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tapdi Oksijen Ozel Saglik ve Egitim Hizlmetleri Sanayi Ticaret AS operates in the general medical and surgical hospitals sector. The company provides service in ?zmir with a medical center and two full fledged hospitals.
85GF Score
Get the complete analysis for IST:TNZTP
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:TNZTP has been successfully added to your 
